Showing results (71-80 of 127) with videos related to
Sort By:
Pageof 13
Clinical Breast Cancer|July 25, 2008
A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk node-negative breast cancerDenise A Yardley, Howard A Burris, Cindy P Farley, et al.Cancer|May 30, 2002
Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research NetworkJohn D Hainsworth, Lisa H Morrissey, Daniel C Scullin, et al.Clinical Breast Cancer|October 28, 2008
A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancerDenise A Yardley, Howard A Burris, Lisa Simons, et al.Clinical Lung Cancer|June 14, 2011
A phase II study of higher dose weekly topotecan in relapsed small-cell lung cancerDavid R Spigel, F Anthony Greco, Howard A Burris, et al.Clinical Advances in Hematology & Oncology : H&O|May 12, 2011
A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancerDavid R Spigel, John D Hainsworth, Howard A Burris, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2010
Phase II study of biweekly pemetrexed and gemcitabine in patients with previously untreated advanced non-small cell lung cancerDavid R Spigel, John D Hainsworth, John H Barton, et al.Cancer Chemotherapy and Pharmacology|April 11, 2016
A phase I dose escalation study of NK012, an SN-38 incorporating macromolecular polymeric micelleHoward A Burris, Jeffrey R Infante, F Anthony Greco, et al.Clinical Breast Cancer|November 26, 2009
Phase II trial of docetaxal plus imatinib mesylate in the treatment of patients with metastatic breast cancerDenise A Yardley, Howard A Burris, Tiffanie Markus, et al.Clinical Lymphoma, Myeloma & Leukemia|April 1, 2014
Rituximab with or without bevacizumab for the treatment of patients with relapsed follicular lymphomaJohn D Hainsworth, F Anthony Greco, Eric L Raefsky, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 31, 2009
Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancerDavid R Spigel, F Anthony Greco, John D Zubkus, et al.Pageof 13